Graphene Investments Sas Jazz Pharmaceuticals PLC Call Options Transaction History
Graphene Investments Sas
- $158 Billion
- Q3 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding JAZZ
# of Institutions
563Shares Held
62.6MCall Options Held
563KPut Options Held
77.8K-
Black Rock Inc. New York, NY6.15MShares$832 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.09MShares$825 Million0.01% of portfolio
-
Lsv Asset Management Chicago, IL2.55MShares$346 Million0.65% of portfolio
-
Capital World Investors Los Angeles, CA2.54MShares$345 Million0.04% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.54MShares$344 Million0.06% of portfolio
About Jazz Pharmaceuticals plc
- Ticker JAZZ
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,680,700
- Market Cap $8.49B
- Description
- Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...